[ Price : $8.95]
Minovia Therapeutics wins an FDA orphan drug designation for its lead investigational therapy, MNV-201, for myelodysplastic syndro...[ Price : $8.95]
FDA accepts for review a Chiesi NDA for a single-inhaler triple therapy designed for the maintenance treatment of asthma in adults...[ Price : $8.95]
Charles River Laboratories names former FDA principal deputy commissioner Namandj N. Bumpus as chair a new global scientific advis...[ Price : $8.95]
FDA warns of serious complications associated with certain uses of radiofrequency microneedling devices, commonly used in aestheti...[ Price : $8.95]
Lilly says its investigational oral GLP-1 drug demonstrated good glycemic control in two Phase 3 trials.[ Price : $8.95]
FDA clears Roches Elecsys pTau 181 blood-based biomarker test for an initial Alzheimers disease assessment.[ Price : $8.95]
FDA releases the 12-page form FDA-483 with six observations from an inspection at Indias Hetero Labs Unit 9 API manufacturing faci...[ Price : $8.95]
FDA grants Akamis Bio a fast-track designation to NG-350A for treating mismatch repair-proficient locally advanced rectal cancer.